Teijin Limited

TSE:3401 Rapport sur les actions

Capitalisation boursière : JP¥309.1b

Teijin Croissance future

Future contrôle des critères 3/6

Teijin devrait augmenter ses bénéfices et son chiffre d'affaires de 80.4% et de 2.8% par an respectivement. Le BPA devrait croître de de 80.1% par an. Le rendement des capitaux propres devrait être 5.1% dans 3 ans.

Informations clés

80.4%

Taux de croissance des bénéfices

80.06%

Taux de croissance du BPA

Chemicals croissance des bénéfices14.0%
Taux de croissance des recettes2.8%
Rendement futur des capitaux propres5.10%
Couverture par les analystes

Low

Dernière mise à jour11 May 2026

Mises à jour récentes de la croissance future

Recent updates

Mise à jour du récit May 02

3401: Deepening Loss Guidance Will Still Signal Weak Earnings And Overvaluation

Analysts kept their price target for Teijin steady at ¥1,368, citing only slight model tweaks in the discount rate, revenue growth, profit margin and future P/E assumptions that do not materially change their view of the shares. What's in the News Teijin cut its consolidated earnings guidance for the fiscal year ending March 31, 2026, and now expects an operating loss of JPY 75,000 million to JPY 85,000 million instead of the previously guided operating income of JPY 5,000 million (Key Developments).
Mise à jour du récit Apr 14

3401: Deepening Loss Outlook Will Still Signal Weak Earnings And Overvaluation

Analysts have revised their price target on Teijin to ¥1,368 from ¥1,328. The new target reflects updated assumptions for revenue growth, profit margins, the discount rate and future P/E multiples.
Mise à jour du récit Mar 31

3401: Stable Assumptions Will Still Signal Weak Earnings And Overvaluation

Analysts have kept their ¥1,328 price target for Teijin unchanged, citing only minor model adjustments to discount rate, revenue growth, profit margin and future P/E assumptions that do not materially alter their view on the shares. Valuation Changes Fair Value: Modelled fair value remains unchanged at ¥1,328.
Mise à jour du récit Mar 17

3401: Higher P/E Assumptions Will Still Signal Weak Earnings Outlook

Narrative Update on Teijin The analyst fair value estimate for Teijin has been revised from ¥1,298 to ¥1,328, with analysts linking this change to updated assumptions for revenue growth, profit margins, and future P/E levels. Valuation Changes Fair Value: Revised slightly higher from ¥1,298 to ¥1,328.
Mise à jour du récit Mar 03

3401: Higher P/E Assumptions Will Still Signal Weak Earnings Outlook

Analysts have raised their price target for Teijin from ¥1,256 to ¥1,298, reflecting slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E. Valuation Changes Fair Value: revised from ¥1,256 to ¥1,298, a modest uplift in the model output.
Mise à jour du récit Feb 16

3401: Modest Margin Gains And Merger Plans Will Still Signal Weak Outlook

Analysts have kept their ¥1,256 price target for Teijin unchanged, citing a slightly lower discount rate, an expected shift from a 1.66% revenue decline to a 0.21% revenue increase, a modest uptick in profit margin, and a reduced assumed future P/E as key factors supporting their maintained view. What's in the News A board meeting is scheduled for December 1, 2025, to consider a basic agreement for an absorption-type merger between Teijin Frontier Co., Ltd., a wholly owned Teijin subsidiary, and Asahi Kasei Advance Corporation, a wholly owned Asahi Kasei subsidiary, with Teijin Frontier as the surviving company (Key Developments).
Mise à jour du récit Feb 02

3401: Aramid Impairment Will Drive Weaker Outlook Despite Merger Plans

Analysts have maintained their fair value estimate for Teijin at ¥1,256. A slightly lower discount rate and a marginally reduced future P/E assumption support a modestly refined price target narrative.
Mise à jour du récit Jan 19

3401: Aramid Impairment Will Drive Cautious Outlook Despite Merger Plans

Analysts have nudged their fair value estimate for Teijin up from ¥1,246 to ¥1,256, citing slightly softer assumed revenue declines, a modestly lower discount rate, and a small adjustment to future P/E expectations as the key drivers of the change. What's in the News Teijin plans a board meeting on December 1, 2025 to consider a basic agreement for an absorption type merger between Teijin Frontier Co., Ltd.
Mise à jour du récit Jan 05

3401: Aramid Impairment And Joint Venture Integration Will Shape Balanced Outlook

Analysts kept their fair value estimate for Teijin steady at ¥1,246, with only small tweaks to the discount rate, long term revenue and margin assumptions, and the future P/E used in their models. This reflects fine tuning rather than a change in their overall view.
Mise à jour du récit Dec 21

3401: Aramid Impairment And Joint Venture Integration Will Define Balanced Outlook

Analysts have nudged their price target on Teijin modestly higher to ¥1,246. This reflects slightly lower perceived risk and a marginally cheaper forward earnings multiple, even as growth and margin assumptions remain essentially unchanged.
Article d’analyse Dec 19

Teijin (TSE:3401) Will Pay A Dividend Of ¥25.00

Teijin Limited ( TSE:3401 ) has announced that it will pay a dividend of ¥25.00 per share on the 4th of June. Based on...
Mise à jour du récit Dec 07

3401: Aramid Impairment And Earnings Resilience Will Shape Balanced Forward Prospects

Analysts have nudged their price target on Teijin slightly higher to JPY 1,246, citing a modestly lower perceived risk profile and stable long term earnings assumptions, despite limited changes to underlying growth and margin forecasts. What's in the News Board meeting scheduled for December 1, 2025, to approve a basic agreement for an absorption type merger between Teijin Frontier and Asahi Kasei Advance, with Teijin Frontier as the surviving company and later becoming a joint venture of Teijin and Asahi Kasei (company disclosure) Resin and plastic processing business briefing session held for analysts and investors, focusing on the outlook and strategy for this segment (company event) Impairment loss of JPY 48.4 billion recorded on fixed assets in the aramid business for the six months ended September 30, 2025, driven by intensifying competition and adverse exchange rate movements, with charges booked in cost of sales and SG&A (company results) Full-year 2025 to 2026 earnings guidance revised downward, with operating income forecast cut from JPY 20 billion to JPY 5 billion and profit attributable to owners of parent now expected to be a loss of JPY 10 billion, mainly due to the aramid impairment and weaker materials and equity method contributions (guidance update) Valuation Changes Fair Value: unchanged at approximately ¥1,246 per share, implying no revision to the analyst central valuation.
Article d’analyse Dec 05

Teijin's (TSE:3401) Dividend Will Be ¥25.00

Teijin Limited ( TSE:3401 ) will pay a dividend of ¥25.00 on the 4th of June. Based on this payment, the dividend yield...
Mise à jour du récit Nov 23

3401: Impairment Loss And Margin Stability Will Define Balanced Investment Prospects

The analyst price target for Teijin has been reaffirmed at ¥1,246 as analysts cite stable forecasts and no material changes in forecasts for discount rate, revenue growth, profit margin, or projected valuation multiples. What's in the News Teijin held a Resin & Plastic Processing Business Briefing Session as part of their Analyst/Investor Day.
Mise à jour du récit Nov 08

3401: Revenue Outlook Will Moderate Risks While Supporting Balanced Opportunity

Analysts have raised their price target for Teijin from ¥1,180 to ¥1,246. This reflects an improved revenue growth outlook and a lower discount rate in updated forecasts.
Nouveau récit Sep 07

Global Demand For Advanced Composites Will Expand Opportunities

Key Takeaways Refocus on high-margin specialty materials and healthcare segments, combined with operational reforms, is expected to drive margin expansion and more stable earnings. Innovation in sustainable materials and divestment of low-yield businesses position the company for new growth opportunities and improved earnings quality.
Article d’analyse Jul 24

Teijin (TSE:3401) Has Debt But No Earnings; Should You Worry?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Article d’analyse Apr 14

Are Investors Undervaluing Teijin Limited (TSE:3401) By 45%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Teijin fair value estimate is JP¥2,032 Teijin's JP¥1,127 share...
Article d’analyse Mar 22

Teijin (TSE:3401) Will Pay A Dividend Of ¥25.00

The board of Teijin Limited ( TSE:3401 ) has announced that it will pay a dividend on the 30th of May, with investors...
Article d’analyse Feb 03

Is Teijin (TSE:3401) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Article d’analyse Dec 31

Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥25.00

Teijin Limited ( TSE:3401 ) will pay a dividend of ¥25.00 on the 30th of May. This takes the dividend yield to 3.7...
Article d’analyse Dec 17

Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥25.00

The board of Teijin Limited ( TSE:3401 ) has announced that it will pay a dividend of ¥25.00 per share on the 30th of...
Article d’analyse Dec 03

Teijin (TSE:3401) Has Announced A Dividend Of ¥25.00

Teijin Limited's ( TSE:3401 ) investors are due to receive a payment of ¥25.00 per share on 30th of May. This will take...
Article d’analyse Dec 01

Is There An Opportunity With Teijin Limited's (TSE:3401) 46% Undervaluation?

Key Insights Teijin's estimated fair value is JP¥2,422 based on 2 Stage Free Cash Flow to Equity Teijin is estimated to...
Article d’analyse Nov 07

Some Confidence Is Lacking In Teijin Limited's (TSE:3401) P/S

With a median price-to-sales (or "P/S") ratio of close to 0.5x in the Chemicals industry in Japan, you could be...
Article d’analyse Oct 17

Be Wary Of Teijin (TSE:3401) And Its Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Article d’analyse Sep 18

Teijin (TSE:3401) Has A Somewhat Strained Balance Sheet

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Article d’analyse Aug 04

Investor Optimism Abounds Teijin Limited (TSE:3401) But Growth Is Lacking

With a median price-to-sales (or "P/S") ratio of close to 0.5x in the Chemicals industry in Japan, you could be...
Article d’analyse Jun 10

A Look At The Fair Value Of Teijin Limited (TSE:3401)

Key Insights Teijin's estimated fair value is JP¥1,442 based on 2 Stage Free Cash Flow to Equity Current share price of...
Article d’analyse May 21

There May Be Underlying Issues With The Quality Of Teijin's (TSE:3401) Earnings

Despite announcing strong earnings, Teijin Limited's ( TSE:3401 ) stock was sluggish. We did some digging and found...
Article d’analyse Apr 09

Teijin (TSE:3401) Will Be Looking To Turn Around Its Returns

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...
Article d’analyse Mar 21

Teijin (TSE:3401) Will Pay A Dividend Of ¥15.00

The board of Teijin Limited ( TSE:3401 ) has announced that it will pay a dividend of ¥15.00 per share on the 31st of...
Article d’analyse Mar 16

Teijin Limited's (TSE:3401) Share Price Matching Investor Opinion

There wouldn't be many who think Teijin Limited's ( TSE:3401 ) price-to-sales (or "P/S") ratio of 0.3x is worth a...
Article d’analyse Feb 28

Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥15.00

The board of Teijin Limited ( TSE:3401 ) has announced that it will pay a dividend of ¥15.00 per share on the 31st of...

Prévisions de croissance des bénéfices et des revenus

TSE:3401 - Estimations futures des analystes et données financières antérieures (JPY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/2029932,50019,93316,90077,9003
3/31/2028929,96019,94013,40062,8505
3/31/2027870,58024,66738,13381,2005
3/31/2026873,190-88,00338,70698,654N/A
12/31/2025909,237-81,60336,446102,187N/A
9/30/2025949,011-76,62016,44385,538N/A
6/30/2025993,247-82,14810,67077,834N/A
3/31/20251,005,471-77,7118,41769,843N/A
12/31/20241,080,075-50,56218,21373,586N/A
9/30/20241,033,772-44,7864,41369,081N/A
6/30/20241,059,05113,49019,46383,941N/A
3/31/20241,032,77310,5994,40969,451N/A
12/31/20231,013,251-7,190N/AN/AN/A
9/30/20231,014,802-25,811-12,71146,544N/A
6/30/20231,019,758-23,108N/AN/AN/A
3/31/20231,018,751-17,695-2,65055,086N/A
12/31/20221,004,148-9,733N/AN/AN/A
9/30/2022983,1229,16327,25287,923N/A
6/30/2022943,99920,628N/AN/AN/A
3/31/2022926,05423,158-110,82089,656N/A
12/31/2021913,776-7,646N/AN/AN/A
9/30/2021895,756-1,088-88,379109,684N/A
6/30/2021883,288-2,558N/AN/AN/A
3/31/2021836,512-6,66246,803107,729N/A
12/31/2020816,02721,908N/AN/AN/A
9/30/2020811,84720,80419,17884,549N/A
6/30/2020818,23820,171N/AN/AN/A
3/31/2020853,74625,25223,89394,214N/A
12/31/2019876,39934,470N/AN/AN/A
9/30/2019885,21131,593N/A88,559N/A
6/30/2019886,83636,353N/AN/AN/A
3/31/2019888,58945,057N/A80,899N/A
12/31/2018879,95846,582N/AN/AN/A
9/30/2018869,74950,281N/A88,221N/A
6/30/2018853,12051,641N/AN/AN/A
3/31/2018834,98545,556N/A80,091N/A
12/31/2017820,78855,795N/AN/AN/A
9/30/2017792,89657,946N/A73,325N/A
6/30/2017765,30452,093N/AN/AN/A
3/31/2017741,29150,133N/A79,040N/A
12/31/2016734,63530,233N/AN/AN/A
9/30/2016751,74027,996N/A85,792N/A
6/30/2016772,40931,336N/AN/AN/A
3/31/2016790,74831,090N/A80,641N/A
12/31/2015799,01441,260N/AN/AN/A
9/30/2015800,82938,724N/A79,542N/A
6/30/2015796,8781,456N/AN/AN/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 3401 devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 0.8% ).

Bénéfices vs marché: 3401 devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.

Croissance élevée des bénéfices: 3401 devrait devenir rentable dans les 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 3401 ( 2.8% par an) devrait croître plus lentement que le marché de JP ( 5.2% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 3401 ( 2.8% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 3401 devrait être faible dans 3 ans ( 5.1 %).


Découvrir les entreprises en croissance

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/21 11:26
Cours de l'action en fin de journée2026/05/21 00:00
Les revenus2026/03/31
Revenus annuels2026/03/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Teijin Limited est couverte par 17 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Mikiya YamadaBarclays
Akiko KuwaharaBofA Global Research
Atsushi IkedaCitigroup Inc